Paul Y. Song - 21 Nov 2023 Form 4 Insider Report for NKGen Biotech, Inc. (NKGN)

Role
Chief Executive Officer, Director
Signature
/s/ Paul Y. Song, M.D.
Issuer symbol
NKGN
Transactions as of
21 Nov 2023
Net transactions value
+$430
Form type
4
Filing time
22 Nov 2023, 17:53:19 UTC
Previous filing
10 Oct 2023
Next filing
28 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKGN Common Stock Purchase $280 +100 +0.06% $2.80* 170,405 21 Nov 2023 Direct
transaction NKGN Common Stock Purchase $150 +53 +0.03% $2.85* 170,458 22 Nov 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.